Science Explorer Back to mapMap

Most cited papers from Centrum für Integrierte Onkologie

What are the most cited papers from Centrum für Integrierte Onkologie?

The most cited paper from Centrum für Integrierte Onkologie is "Nivolumab in Previously Untreated Melanoma without BRAF Mutation" (Caroline Robert et al., 2014), with 5,431 citations. Next come "European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary" (1,390) and "Consensus guidelines for the definition, detection and interpretation of immunogenic cell death" (1,116).

Showing 50 of 60 papers. Every paper with more than 134 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Nivolumab in Previously Untreated Melanoma without BRAF Mutation Caroline Robert et al. · New England Journal of Medicine Open access 16 Nov 2014 5,431
2 European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary Jerry P. Nolan, Jasmeet Soar, David Anthony Zideman et al. · Resuscitation Open access Oct 2010 1,390
3 Consensus guidelines for the definition, detection and interpretation of immunogenic cell death Lorenzo Galluzzi et al. · Journal for ImmunoTherapy of Cancer Open access Mar 2020 1,116
4 Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial Harry G M M Bartelink et al. · The Lancet Oncology Open access 8 Dec 2014 696
5 Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial Ernst-Rüdiger Kuse et al. · The Lancet Open access 27 Apr 2007 694
6 Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study Rolf Dieter Issels, Lars Hartwin Lindner, Jaap Verweij et al. · The Lancet Oncology Open access May 2010 665
7 Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study Andreas Engert, Volker Diehl, Jeremy G. Franklin et al. · Journal of Clinical Oncology 24 Aug 2009 500
8 Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer Salah‐Eddin Al‐Batran et al. · JAMA Oncology Open access 27 Apr 2017 485
9 Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study Emmanuel Ekanem et al. · Nature Medicine Open access139 authors Jul 2024 484
10 European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update Johan A. Maertens, Oscar Marchetti, Raoul Herbrecht et al. · Bone Marrow Transplantation 26 Jul 2010 469
11 Rucaparib or Physician’s Choice in Metastatic Prostate Cancer Karim S. Fizazi et al. · New England Journal of Medicine Open access 16 Feb 2023 447
12 The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers Christopher Ian Amos et al. · Cancer Epidemiology Biomarkers & Prevention Open access 3 Oct 2016 397
13 Protein size and cerebrospinal fluid composition Klaus Felgenhauer · Journal of Molecular Medicine Dec 1974 396
14 Mapping of the human IL10 gene and further characterization of the 5' flanking sequence Joyce Eskdale, Dieter Kube, Hans Tesch et al. · Immunogenetics 2 Jun 1997 386
15 Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection Gerd Fätkenheuer et al. · New England Journal of Medicine Open access Oct 2008 365
16 Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF) Emmanuel Ekanem et al. · EP Europace Open access 14 Apr 2022 353
17 Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants for the SAKK and the German CML Study Group et al. · Leukemia Open access 14 Aug 2017 342
18 Tumor-Specific T Cell Activation by Recombinant Immunoreceptors: CD3ζ Signaling and CD28 Costimulation Are Simultaneously Required for Efficient IL-2 Secretion and Can Be Integrated Into One Combined CD28/CD3ζ Signaling Receptor Molecule Andreas A. Hombach, Anja Wieczarkowiecz, Thomas Marquardt et al. · The Journal of Immunology Dec 2001 298
19 Neuroprotection mediated by changes in the endothelial actin cytoskeleton Ulrich Laufs, Matthias Endres, Nancy E. Stagliano et al. · Journal of Clinical Investigation Open access Jul 2000 280
20 Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV Lida Kalmanti et al. · Leukemia 13 Feb 2015 278
21 Altered function of insulin receptor substrate-1–deficient mouse islets and cultured β-cell lines Rohit Kulkarni, Jonathon N. Winnay, Molly S. Daniels et al. · Journal of Clinical Investigation Open access 15 Dec 1999 275
22 Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype Vera Großmann et al. · Blood Open access 20 Oct 2011 270
23 DIURNAL SALIVARY CORTISOL PATTERNS DURING PREGNANCY AND AFTER DELIVERY: RELATIONSHIP TO PLASMA CORTICOTROPHIN‐RELEASING‐HORMONE Bruno Allolio, Jochen H. O. Hoffmann, E.A. Linton et al. · Clinical Endocrinology Aug 1990 246
24 Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma Caroline Robert et al. · Journal of Clinical Oncology Open access 30 Sep 2020 239
25 Insulin Induces Upregulation of Vascular AT1Receptor Gene Expression by Posttranscriptional Mechanisms Georg Nickenig, J. Röling, Kerstin Strehlow et al. · Circulation Dec 1998 228
26 Adoptive immunotherapy with genetically engineered T cells: modification of the IgG1 Fc ‘spacer’ domain in the extracellular moiety of chimeric antigen receptors avoids ‘off-target’ activation and unintended initiation of an innate immune response Andreas A. Hombach, Andreas A. Hombach, Hinrich Abken · Gene Therapy 17 Jun 2010 228
27 Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease Andreas Josting, Christian J. Rudolph, Marcel Reiser et al. · Annals of Oncology Open access Oct 2002 225
28 Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer – A study based on the EORTC trial 22881–10882 ‘boost versus no boost’ Sandra Collette, Laurence Collette, Tom Budiharto et al. · European Journal of Cancer 30 Aug 2008 225
29 Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018 Heinrike Wilkens et al. · International Journal of Cardiology 28 Aug 2018 221
30 Isolation of the Human Interleukin 10 Promoter. Characterization of the Promoter Activity in Burkitt's Lymphoma Cell Lines Dieter Kube, Cornelia Platzer, Andreas von Knethen et al. · Cytokine 1995 216
31 GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany Wolfgang Andreas Bethge et al. · Blood Open access 22 Mar 2022 215
32 Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series Laurent Pierot et al. · Journal of NeuroInterventional Surgery Open access 30 Sep 2017 206
33 Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project Andy C. Rawstron et al. · Cytometry Part B Clinical Cytometry Open access 10 Oct 2017 203
34 Hereditary Breast and Ovarian Cancer Alfons Meindl, Nina Caroline Ditsch, Karin Kast et al. · Deutsches Ärzteblatt international Open access 13 May 2011 198
35 Local Activity Determines Functional Connectivity in the Resting Human Brain: A Simultaneous FDG-PET/fMRI Study Valentin Riedl, Katarzyna Bienkowska, Carola Strobel et al. · Journal of Neuroscience Open access 30 Apr 2014 194
36 Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: systematic review and meta-analysis of randomised trials Matthieu Roustit, S. Blaise, Yannick Allanore et al. · Annals of the Rheumatic Diseases Review 21 Feb 2013 188
37 Sympatho-renal axis in chronic disease Paul A. Sobotka, Felix Mahfoud, Markus Peter Schlaich et al. · Clinical Research in Cardiology Open access 18 Jun 2011 180
38 Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology Oliver A. Cornely, Angelika Böhme, Dieter Buchheidt et al. · Haematologica Open access 9 Dec 2008 178
39 Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial Peter G. Kremsner et al. · The Lancet Infectious Diseases Open access177 authors 23 Nov 2021 176
40 Endothelial cell‐derived angiopoietin‐2 is a therapeutic target in treatment‐naive and bevacizumab‐resistant glioblastoma Alexander Scholz et al. · EMBO Molecular Medicine Open access 14 Dec 2015 174
41 Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves Sabine Bleiziffer et al. · European Heart Journal Open access 22 Jun 2020 173
42 Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial Guillermo Garcia‐Manero et al. · The Lancet Oncology 8 Mar 2016 173
43 Leitlinien zur Therapie der chronischen Herzinsuffizienz Uta Charlotte Hoppe, Michael C Böhm, Rainer Dietz et al. · Zeitschrift für Kardiologie Open access 27 Jul 2005 169
44 S2k-Leitlinie nicht alkoholische Fettlebererkrankungen Elke Roeb, Hans‐Michael Steffen, Heike Bantel et al. · Zeitschrift für Gastroenterologie 13 Jul 2015 162
45 Die klinischen Syndrome K.-A. Jochheim, F. Loew, August Rütt Book chapter 1961 162
46 The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis Philipp Erben, Juliana Schwaab, Georgia Metzgeroth et al. · Annals of Hematology 26 Nov 2013 161
47 Fractional programming: Applications and algorithms Siegfried Schaible · European Journal of Operational Research Jun 1981 156
48 Direct comparison of spatially normalized PET and SPECT scans in Alzheimer's disease. Karl Herholz, Helge Schopphoff, Mathias V. Schmidt et al. · PubMed 2002 153
49 Transcatheter Mitral Valve Replacement After Surgical Repair or Replacement Matheus Simonato et al. · Circulation Open access 25 Sep 2020 151
50 Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma Hans P. M. W. Wildiers, Marcel Reiser · Critical Reviews in Oncology/Hematology 16 Mar 2010 149

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.